Antimicrobial resistance (AMR) among gram-negative bacilli Background: is a global health problem. Surveillance of AMR is required to advise on empirical antimicrobial therapy. This study aimed at evaluating the frequency and the AMR patterns of gram-negative isolates from patients treated in eight hospitals in Khartoum State, Sudan.
Introduction
Antimicrobial resistance (AMR) constitutes a continuously growing threat to the effective treatment of microbial infections 1 . However, the direct impact of AMR on the health of hospitalized patients or the people in the community, as well as the financial burden experienced by health care systems in managing the infections and complications due to AMR, are still mostly uncertain 2 . Antibacterial drugs are widely used worldwide both in human health and food industry. Overuse of these medications can favor the selection and the spread of multidrug resistant (MDR) bacteria 1 . Multi drug resistance is defined as resistance to at least three different antibiotic groups, as reported by Masgala and Kostaki 3 . Antibiotic resistance among a variety of bacterial species is increasing in healthcare and community setting. Extended-spectrum β-lactamase and carbapenemase production are the most frequently emerging resistance mechanisms among gram-negative bacilli 4 . Gram-negative bacilli including Enterobacteriaceae and non-lactose fermenting bacteria such as Pseudomonas spp. and Acinetobacter spp. are the main causes of hospital-acquired infection in critical care units 2, 5 . The antibiotic resistance rates among these organisms have amplified uncontrollably in a matter of a few years to become worldwide 2 . According to the Centre for Disease Control and Prevention, gram-negative bacilli are able to develop antibiotic resistance through multiple methods and are particularly competent at spreading the resistance among species via horizontal gene transfer 6 . The enigma of AMR is particularly plaguing low-and middle-income countries, where infectious diseases are the commonest cause of hospitalization and death; and the newer antibiotics cannot be afforded 7 .
AMR surveillance is key for determining the prevalence patterns of AMR, which is fundamental for the development of national and international treatment strategies. Most of the available surveillance data are derived from developed countries; the studies conducted in developing countries are unfortunately not adequate.
This surveillance study was undertaken in order to find out the different types of the AMR patterns of bacterial pathogens isolated from patients in Khartoum State, Sudan. This study may help in formulating antibiotic policies tailored to our hospitals. These data can be used as "information for action" antibiotic stewardship and interventions to optimize antibiotic prescribing practice, therefore prolongs the usefulness of existing antibiotics. Most gram-negative Bacilli isolates were further identified and confirmed by PCR. Guanidine chloride method, as described by Alsadig et al. 9 , was used for DNA extraction followed by PCR which it was carried out using thermal cycler (analytikjena® Biometra TADVANCED, Germany), by using the following primers (Macrogen, Korea), using species-specific primers for Klebsiella pneumoniae, Escherichia coli, Pseudomonas aeruginosa, Acinetobacter baumannii and Universal 16S rRNA primers ( Table 1) the reaction was carried out in a total reaction volume of 25 μl (5μl Master mix of Maxime RT premix kit (iNtRON Biotechnology, Seongnam, Korea), 0.6 μl of forward primer, 0.6 μl of reverse primer, 2μl of DNA and 16.8 μl deionized sterile water). The cycle condition as the following: initial denaturation step at 94°C for 5-min, followed by 30 cycles of denaturation at 94°C for 45 seconds, primer annealing temperature according to the primers Table 1 for 45 seconds, followed by step of elongation at 72°C for 60 seconds and the final elongation at 72°C for 5 min 10 . The purity and integrity of each PCR product was evaluated electrophoresis in a 2% agarose gel in TBE 1X, that contain 2.5 μl of (20mg/ml) ethidium bromide at 100V for 40 min. The specific amplified product were detected by comparing with 100 base-pairs standard DNA ladder (iNtRON BIOTECHNOLOGY, Seongnam, Korea) Bands were visualized under U.V transilluminater (analytikjena® Biometra BDAcompact, Germany). The PCR product of 16SrRNA were purified and Sanger sequencing was performed by Macrogen Company (Seoul, Korea). Then nucleotides sequences of the genes 16SrRNA achieved were searched for sequence similarity using nucleotide BLAST for species identification 11 .
Methods

Study design and clinical strains
Antimicrobial susceptibility testing Susceptibility testing was performed using the Kirby-Bauer disc-diffusion method; each isolate was swabbed on the Muller-Hinton agar and the antibiotic discs were placed on top and incubated at 37°C for 18-24 hours 12 . all isolates were tested against the following antibiotic disc (Mast Diagnostic): amoxycillin clavulanate (AMC) (30 μg), cefuroxime (CXM) (30 μg), cephalexin (CL) (30 μg), ceftriaxone (CRO) (30 μg), ceftazidime (CAZ) (30 μg), meropenem (MEM) (10 μg), imipenem (IPM) (10 μg), amikacin (AK) (30 μg), gentamicin (Gen) (10 μg), ciprofloxacin (CIP) (5 μg), trimethoprim-sulfamethoxazole (SXT) (25 μg), temocillin (TEM) (30 μg), azteroname (AZT) (30 μg) and nitrofrantoine (NIT) (300 μg). Results were interpreted according to the Clinical Laboratory Standards Institute (CLSI) guidelines 12 .
Classification of MDR gram-negative Bacilli MDR has been considered for clinically significant gramnegative Bacilli such as E. coli, K. pneumoniae, P. aeruginosa, and A. baumannii based on the aforementioned antimicrobial resistance definition. Classes of antibiotics used for MDR-GNB analysis were aminoglycoside (AMG), cephalosporins (CEPH), carbapenems (CARB), and fluroquinolones (FQ) as follows: bacteria that were MDR for four classes of antibiotics (AMG+ CEPH+ CARB+ FQ) and bacteria that were MDR for three classes of antibiotics (either AMG+CEPH +FQ, CARB+CEPH+FQ, AMG+CEPH+CARB, or AMG+FQ+CARB) 3 .
Cephalosporin resistance was defined as resistance to ceftriaxone and ceftazidime, except for P. aeruginosa, where only ceftazidime was used. Carbapenem resistance was defined as resistance to both meropenem and imipenem. Aminoglycoside resistance was defined as resistance to both gentamicin and amikacin, Ciprofloxacin resistance was considered an indication to fluoroquinolones resistance.
Ethical consideration
Formal permission was obtained from the managers of Soba University Hospital and the Institutional Research Ethics Committee of the Institute of Endemic Diseases, University of Khartoum, approved this study under reference number IEND_REC 12/2017. Patient consent was waived by the Research Ethics Committee.
Statistical analysis
Data were analysed using Microsoft Excel and SPSS version 20.0. Cross-tabulation was used to present the different relations between data, qualitative data were performed using a χ 2 test (significance was set at p≤0.05), which was performed to find the differences between bacterial isolates with resistance to at least one class of antibiotics by specimens (blood, urine, wound and other samples) p-values were determined for primary and secondary outcomes.
Results
Bacterial identification
Isolated Gram-negative bacilli showed different strains, including E. coli (123 isolates, 17%), K. pneumoniae (249 isolates,34%), P. aeruginosa (153 isolates, 21%), A. baumannii (75 isolates, 10%), Burkholderia cepacia (42 isolates, 6%), Proteus mirabilis and Proteus vulgaris (28 isolates, 4%), Enterobacter colecaes (28 isolates, 4%), Stenotrophomonas maltophilia (21 isolates, 2.8%) and other gram-negative bacilli (15 isolates, 2.2%).
While isolates were distributed among the different hospital units, most of the pathogenic strains were isolated from neonatal intensive care unit (ICU) (182 isolates, 24.8%) mainly K. pneumoniae (77 isolate, 42.3%) and pediatric units (175 isolates 23.8%) the most prevalent strains were K. pneumoniae (50 isolate, 29%) and P. aeruginosa (44 isolates, 25.1), while medicine (147 isolates, 20%), K. pneumoniae and E.coli (45 isolates 30.6%) for both. For the surgery unit (103 isolates, 14%) renal unit (78 isolates, 10.7%) and ICU (49 isolates, 6.7%) mainly K. pneumoniae (19 isolates, 39%), P. aeruginosa and A. baumannii were (9 isolates, 20.4) for both. Klebsiella pneumoniae was the most isolated organism from all hospital units. The distribution of different gram-negative isolates is shown in Table 2 .
With regard to the distribution of the isolates among different clinical specimens, Klebsiella pneumoniae and Pseudomonas aeruginosa were isolated mainly in blood specimens 39% and 25% respectively, while K. pneumoniae and E.coli were 36% and 30% of urine samples. A. baumannii was isolated from 14% of wound specimens and P. aeruginosa was isolated from 23% of wound specimens. For more details about gram-negative bacilli among different specimen see Table 3 .
Antimicrobial resistance pattern of clinical isolates Antibiotic resistance pattern are shown in Figure 1 . Out of 734 isolates tested using the disk diffusion method, the highest percentage of resistance, in 97% and 93.5% of isolates, were found against ampicillin and cephalexin, respectively, followed by amoxicillin/clavulanic acid(90%), cefotaxime (89.7%), ceftriaxone (88.4%) and ceftazidime (79.2%). In addition, co-trimoxazole and nitrofurantoin resistance were detected in 74.4% and 75.2% of isolates, respectively. Resistance rates also were high in ciprofloxacin (45.2%), gentamicin (52.5%) and amikacin (18.3%). Meropenem and imipenem were the most effective antibiotic tested, with resistance observed in 21.6% and 16.2% of isolates, respectively.
The antimicrobial resistance patterns of most commonly isolated organisms are shown in Figure 2 . K. pneumoniae resistant pattern as the following (22%) of them were resistant to meropenem while (11%) were resistant to imipenem, ceftazidime (80.6%), Gentamicin (52%), ciprofloxacin (42%) and amikacin (16.7%). With regard to the E. coli antimicrobial resistant pattern, meropenem (9%), imipenem (8%), ceftazidime (84.2%), ciprofloxacin (66.4%), Gentamicin (53.1%) and amikacin (12.0%). In Pseudomonas aeruginosa the resistance rate was meropenem (20%), imipenem (22%) ceftazidime (81%) followed by gentamicin (57.5%), ciprofloxacin (22.5%) and amikacin (9.5%). The rate of antimicrobial resistant among A. baumannii was as the following; meropenem (73.7%), imipenem (66.7%), amikacin (63.2%), gentamicin (79%) and ciprofloxacin (79%).
Multidrug resistance patterns among gram negative Bacilli
The gram-negative bacilli that were resistant to several antibiotic groups are shown in 
Discussion
Infection with MDR gram-negative Bacilli is a major problem worldwide, associated with increased patients morbidity and mortality 17 . In Sudan, the increasing number of MDR bacteria is a real clinical challenge 18, 19 . This study was undertaken; to identify the different patterns of AMR in bacterial pathogens isolated from patients treated in various wards of hospitals.
In this study, K. pneumoniae and P. aeruginosa strains were more prevalent in blood specimens while K. pneumoniae and E.coli strains were more frequently isolated in urine specimens.
K. pneumoniae is a prominent pathogen causing both hospital-acquired and community-associated infections, including bacteremia, wound infection, pneumonia, urinary tract infections and other infections 20, 21 . In this study, K. pneumoniae was the most commonly isolated organism from the blood specimens mainly in neonatal sepsis in a high rate (39.8%). Most of these strains resistant to cephalosporins and other class of antibiotics including carbapenem as reported worldwide 7, 21, 22 .
E. coli is regarded as the commonest pathogen of the urinary tract, causing complicated and uncomplicated urinary tract infections 23 . In this study, the most frequently observed pathogens in urine specimens were E. coli (30%) and K. pneumoniae (36%). This finding is in harmony with the results of several other studies, including: de Francesco et al., who found that E.coli was the commonest GNB (42.4%) isolate from urine specimens of patients with urinary tract infection 24 ; a study in Tanzania reported 38% of E.coli isolated from urinary specimens 25 and other studies from Pakistan and India 25,26 .
In this study, non-lactose-fermenting gram-negative bacilli such as P. aeruginosa and A. baumannii were mostly encountered in ICU patients, these organisms were isolated in 20.4% of samples, and were found in different clinical samples such as: blood, wound and sputum. This finding agrees with a study by Vincent et al. that reported P. aeruginosa and A. baumannii were frequently isolated from ICU patients by Vincent et al. 27 ; Jitendra et al., reported that A. baumannii was the second most common pathogen in an ICU of a tertiary care center 28 . Concerning the infection type, we found that P. aeruginosa were associated with 25% of blood stream infections and 23% of wound infection, while A. baumannii mainly associated with wound infection in 14% in agree with Gales et al. 2010 29 .
Resistance of gram-negative bacilli is widespread and multidrug resistance has been reported in many studies 2,4,5 , causing challenges in the treatment of nosocomial infections. The resistance pattern was commonly reported in classes such as cephalosporins, carbapenem, aminoglycosides and quinolones [30] [31] [32] . In this study, we observed high rates of resistance to extended-spectrum β-lactamases (ESBL), resistance to cephalexin, cefuroxime, ceftazidime and ceftriaxone, in addition to resistance to ampicillin and amoxicillin/clavulanic acid.
The analysis of the antimicrobial susceptibility patterns of the study isolates showed high rate of MDR organisms that were resistant to three or more classes of antibiotics, including carbapenem and aminoglycosides. This pattern was observed mainly among Acinetobacter baumannii, Pseudomonas aeruginosa and Klebsiella pneumoniae.
The most resistant strain was Acinetobacter baumannii, being resistant to all four classes of antibiotics used in 50.6% of isolates. A total of 73.7% of A. baumannii were found to be resistant to meropenem, and 66.7% to imipenem, while in the cephalosporin class, more than 91% of the isolates were resistant. A. baumannii also have high resistance rate to aminoglycosides and quinolones (63.2% for amikacin and 79% for both gentamicin and ciprofloxacin). This increasing resistance among A. baumannii has become a public-health issue, because this bacterium frequently causes nosocomial infections 31 .
In this study the most common clinical isolates of the Enterobacteriaceae family were K. pneumonia and E. coli. In both species, there was a high prevalence of resistance against quinolones, aminoglycosides and beta-lactams. Rates of resistance to carbapenems were alarmingly high: 22% in K. pneumoniae and 9% in E. coli. These bacteria have high resistance rate to ceftazidime and cephalexin, (80.6% and 92%, respectively). These rates are much higher than those observed in 2013 by Ali in Soba University hospital, who found that ceftriaxone and ceftazidime resistance rates ranged from 56% to 79% 21, 33 . Aminoglycoside (specifically amikacin) resistance rates among K. pneumoniae and E. coli were 16.7% and 12.1%, respectively, which is higher than those observed by Lee in 2013, who found the resistance rate to amikacin was 6.2% in K. pneumoniae and 1.3% in E. coli 30 . In this study Gentamicin resistance among both K. pneumoniae and E. coli was 53%, which is a high resistance rate. E. coli was highly resistant to quinolones like ciprofloxacin (in 66.4%), whereas K. pneumoniae was resistant in 42% of isolates. This finding is much lower than that observed by Moolchandani et al. in 2017 32 .
Pseudomonas aeruginosa was resistant to carbapenem in 22% of isolates and was highly resistant to ceftazidime (in 81% of isolates) followed by gentamicin (57.5%), ciprofloxacin (22.5%) and amikacin (9.5%). resistance to many antibiotic among P. aeruginosa was reported in many studies 4, 34 .
The high level of resistance in the current study can be attributed to the unrestricted use of antibiotics in Sudanese hospitals; this injudicious use has been shown to have, an important role in increasing carbapenem resistance 32 . During this study, 134 gram negative bacilli resistant to three or four classes of antibiotics were isolated over a period of six months, which is relatively higher rate than the rate reported in a previous study also conducted in SUH over 30 months, from January 2011 to June 2013 33 . This concerning finding indicates the rapid acceleration in the rate of emergence of MDR organisms in our local sittings. Moreover, 80 bacterial strains were resistant to all available antibiotics,including meropenem.
In addition, microbiology laboratories play a crucial role against the spread of antimicrobial resistance by accurately identifying causative pathogens and detecting their antimicrobial susceptibility profile, so as to guide the proper use of antibiotics by the care providers. Unfortunately, in Sudan the lack of reliable microbiology laboratory services adds yet another layer to the multifactorial problem of MDR organisms' epidemic in our country. Most of the laboratories in our country use the disk diffusion method for antimicrobial susceptibility testing; however, there are no policies regarding phenotypic screening for antibiotic resistance among certain organisms; resulting in that the laboratory report may not be accurate and misguide the doctors. For instance, in the disk diffusion method, if the inhibitory zone around ceftazidime was ≤22 mm, ideally this should trigger testing for the presence of ESBLs in the isolated pathogen, because the presence of these enzymes renders all penicillins, cephalosporins and monobactams 12 useless against that certain isolate, even if they shows susceptible results in the routine test. Yet, this extra step is not taken and only the routine susceptibility results will be reported, which may inaccurately show some antibiotics as susceptible while in reality the organism is resistant to them. Lastly, there is a limited choice of available antibiotics in Sudan; the most widely available are cephalosporins, which makes them the backbone of treating infectious diseases regardless of the isolate or its susceptibility profile. Carbapenems are believed to treat all evils, once they were reserved for the treatment of MDR organisms causing systemic infections 4 , but the recent trend led to over use them for treating infections that can be managed by less potent antibiotics, contributing to this vicious cycle that aggravate the AMR issue even more.
Conclusion
In conclusion, there was a high prevalence of gram negative bacterial pathogen associated hospital and community acquired infections, with increasing rates of resistance to available antibiotics. Strict infection control measures should be implemented, and antimicrobial stewardship should be initiated and policed to decrease the spread of MDR pathogens in Sudanese hospitals.
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